LWLucy A. Ward

Lucy A. Ward

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lucy A. Ward has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Edwin O. Nuzum

    Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA

    1 shared publication
  • George W. Christopher

    Joint Program Management Office, Medical Countermeasure Systems, 1564 Freedman Drive, Fort Detrick, MD 21702, USA

    1 shared publication
  • Helen F. Schiltz

    Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Bethesda, MD 20892-9826, USA

    1 shared publication
  • Mark T. Albrecht

    Biomedical Advanced Research and Development Authority, Department of Health and Human Services, Washington, DC 20024, USA

    1 shared publication
  • Nicole Kilgore

    Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical, U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, Fort Detrick, MD 21702, USA

    1 shared publication
  • Rebecca Kurnat

    Medical Countermeasure Systems, Department of Defense, Ft. Detrick, Frederick, MD 21702, USA

    1 shared publication

Latest Publications

  • Open Access

    Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop

    by Rona Hirschberg, Lucy A. Ward, Nicole Kilgore, Rebecca Kurnat, Helen Schiltz, Mark T. Albrecht, George W. Christopher, Ed Nuzum

    On August 22–23, 2013, agencies within the United States Department of Defense (DoD) and the Department of Health and Human Services (HHS) sponsored the Filovirus Medical Countermeasures (MCMs) Workshop as an extension of the activities of the Filovirus Animal Non-clinical Group (FANG). The FANG is a federally-recognized multi-Agency group established in 2011 to coordinate and facilitate U.S. government (USG) efforts to develop filovirus MCMs. The workshop brought together government, academic and industry experts to consider the needs for filovirus MCMs and evaluate the status of the product development pipeline. This report summarizes speaker presentations and highlights progress and challenges remaining in the field.